Press Digest: Financial Times - April 17

Prometheus Biosciences

17/04/2023 24:59

April 17 (Reuters) - The following are the top stories
in the Financial Times. Reuters has not verified these stories
and does not vouch for their accuracy.
    
    Headlines
    - Bank of England considers major reform of deposit
guarantee scheme
    
    - Merck buys Prometheus Biosciences for almost $11 bln
    
    - Poland and Hungary defy Brussels to halt Ukraine grain
imports
    
    - Nurses ready to strike all year if needed, union head
warns
    
    Overview
    - The Bank of England is considering a major overhaul of its
deposit guarantee scheme, including boosting the amount covered
for businesses and forcing banks to pre-fund the system to a
greater extent to ensure faster access to cash when a lender
collapses.
    
    - Merck  MRK.N  has agreed to buy Prometheus Biosciences
 RXDX.O  for $10.8 billion as the U.S. drugmaker bolsters it
pipeline ahead of the possible loss of exclusivity over its
best-selling cancer drug later this decade.
    
    - Poland and Hungary have temporarily halted imports of
Ukrainian grain despite a warning from Brussels that such
unilateral action would contravene EU trade policy.
    
    - Nurses strikes in England could continue until Christmas
if the government does not return with a higher pay offer for
the NHS, the leader of the Royal College of Nursing said on
Sunday, as health employers warned that further walkouts would
pose significant risks to patient safety.

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))